These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 20060154)
21. Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome. Joshi MG; Lee AK; Loda M; Camus MG; Pedersen C; Heatley GJ; Hughes KS Cancer; 1996 Feb; 77(3):490-8. PubMed ID: 8630956 [TBL] [Abstract][Full Text] [Related]
22. Does routine grading of invasive lobular cancer of the breast have the same prognostic significance as for ductal cancers? Sinha PS; Bendall S; Bates T Eur J Surg Oncol; 2000 Dec; 26(8):733-7. PubMed ID: 11087636 [TBL] [Abstract][Full Text] [Related]
23. Cytohistomorphological grading of breast carcinoma with special reference to apoptotic rates and lymph node metastasis. Khan N; Rana F; Afroz N; Khan MA Indian J Pathol Microbiol; 2007 Jul; 50(3):613-8. PubMed ID: 17883162 [TBL] [Abstract][Full Text] [Related]
24. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma. Di Saverio S; Gutierrez J; Avisar E Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874 [TBL] [Abstract][Full Text] [Related]
25. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence. Jeschke U; Mylonas I; Kuhn C; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K Anticancer Res; 2007; 27(4A):1969-74. PubMed ID: 17649807 [TBL] [Abstract][Full Text] [Related]
26. Thermography. Its relation to pathologic characteristics, vascularity, proliferation rate, and survival of patients with invasive ductal carcinoma of the breast. Sterns EE; Zee B; SenGupta S; Saunders FW Cancer; 1996 Apr; 77(7):1324-8. PubMed ID: 8608510 [TBL] [Abstract][Full Text] [Related]
27. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions. White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459 [TBL] [Abstract][Full Text] [Related]
28. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Barth A; Craig PH; Silverstein MJ Cancer; 1997 May; 79(10):1918-22. PubMed ID: 9149018 [TBL] [Abstract][Full Text] [Related]
29. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes. Truong PT; Berthelet E; Lee J; Kader HA; Olivotto IA Cancer; 2005 May; 103(10):2006-14. PubMed ID: 15812825 [TBL] [Abstract][Full Text] [Related]
30. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up. Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650 [TBL] [Abstract][Full Text] [Related]
31. Prognostic value of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinoma breast. Aziz SA; Pervez S; Khan SM; Kayani N; Nasir MI J Coll Physicians Surg Pak; 2005 Apr; 15(4):225-9. PubMed ID: 15857596 [TBL] [Abstract][Full Text] [Related]
32. Endothelial area as a prognostic indicator for invasive breast carcinoma. Simpson JF; Ahn C; Battifora H; Esteban JM Cancer; 1996 May; 77(10):2077-85. PubMed ID: 8640673 [TBL] [Abstract][Full Text] [Related]
33. TRAIL death receptor-4 expression positively correlates with the tumor grade in breast cancer patients with invasive ductal carcinoma. Sanlioglu AD; Korcum AF; Pestereli E; Erdogan G; Karaveli S; Savas B; Griffith TS; Sanlioglu S Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):716-23. PubMed ID: 17512128 [TBL] [Abstract][Full Text] [Related]
34. In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor. Janssen EA; Baak JP; Guervós MA; van Diest PJ; Jiwa M; Hermsen MA J Pathol; 2003 Dec; 201(4):555-61. PubMed ID: 14648658 [TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of molecular classification of breast invasive ductal carcinoma. Muñoz M; Fernández-Aceñero MJ; Martín S; Schneider J Arch Gynecol Obstet; 2009 Jul; 280(1):43-8. PubMed ID: 19082617 [TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of scoring system based on histological heterogeneity of invasive ductal carcinoma for node-negative breast cancer patients. Kurosumi M; Tabei T; Inoue K; Takei H; Ninomiya J; Naganuma R; Suemasu K; Higashi Y; Tsuchiya E Oncol Rep; 2003; 10(4):833-7. PubMed ID: 12792731 [TBL] [Abstract][Full Text] [Related]
37. Prognostic factors for death after an isolated local recurrence in patients with early-stage breast carcinoma. Lê MG; Arriagada R; Spielmann M; Guinebretière JM; Rochard F Cancer; 2002 Jun; 94(11):2813-20. PubMed ID: 12115367 [TBL] [Abstract][Full Text] [Related]
38. Classification and grading of invasive breast carcinoma. Elston CW Verh Dtsch Ges Pathol; 2005; 89():35-44. PubMed ID: 18035670 [TBL] [Abstract][Full Text] [Related]
39. Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer. Nakamura Y; Yasuoka H; Tsujimoto M; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K Breast Cancer Res Treat; 2005 May; 91(2):125-32. PubMed ID: 15868440 [TBL] [Abstract][Full Text] [Related]
40. Factors predicting in-breast tumor recurrence after breast-conserving surgery. Mechera R; Viehl CT; Oertli D Breast Cancer Res Treat; 2009 Jul; 116(1):171-7. PubMed ID: 18815880 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]